Systematic study on the preparation of BSA nanoparticles

Area of Science:

• Biomaterials Science
• Nanotechnology
• Pharmaceutical Sciences

Background:

• Albumins, particularly bovine serum albumin (BSA), are utilized as nanoparticle drug carriers.
• Nanoparticle size significantly impacts drug bioavailability and in vivo behavior after intravenous administration.

Purpose of the Study:

• To comprehensively study the preparation of BSA nanoparticles using a coacervation method.
• To optimize nanoparticle size, distribution, and surface charge for effective drug delivery applications.

Main Methods:

• Investigated the impact of experimental variables (BSA content, pH, ionic strength, temperature, ethanol addition rate/volume) on nanoparticle characteristics.
• Controlled particle size by adjusting protein self-assembly phenomena.
• Modulated surface charge through cross-linking.
• Assessed long-term colloidal stability over two months.

Main Results:

• Achieved small BSA nanoparticles with narrow size distribution under conditions promoting high molecular repulsion (pH far from isoelectric point, low salt concentration).
• Demonstrated that preparation conditions influence nucleation rate, particle growth, and nanoparticle yield.
• Confirmed surface charge modulation via cross-linking and evaluated long-term colloidal stability.

Conclusions:

• Optimized coacervation method yields BSA nanoparticles suitable for drug delivery.
• Understanding and controlling preparation parameters are crucial for tailoring nanoparticle properties.
• BSA nanoparticles exhibit promising characteristics for pharmaceutical applications, including controlled size and stability.